A leading immuno-oncology biotech company with a pipeline of novel, first-in-class clinical stage assets needed medical support for multiple clinical and medical affairs activities in Europe and the United States.
Our support included providing advice and assistance with the following:
- clinical strategy and execution of the clinical development plans for the company’s drug candidates
- drug safety and pharmacovigilance
- fostering existing and future relationships with key opinion leaders, medical advisors and medical advisory boards.
We also assessed portfolio expansion opportunities and other corporate development activities from a clinical development and medical perspective.